Robert Barrow, Chief Executive Officer at Mind Medicine (MindMed) Inc. (MNMD), sold 33,038 shares at $9.50 ($314K) on 2024-03-25, disclosed to the SEC on 2024-03-26.
Scheduled sale ($314k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 16,519 | $157K | 50.0% |
| 2 | $9.50 | 16,519 | $157K | 50.0% |
| Total | $9.50 avg | 33,038 | $314K | 100% |
| Filing → |
| DFTX | SELL | 2026-06-26 | $1.3M | — | Filing → |
| DFTX | SELL | 2026-03-26 | $451K | — | Filing → |
| MNMD | SELL | 2025-12-29 | $678K | — | Filing → |